Utility of 96 well Caco-2 cell system for increased throughput of P-gp screening in drug discovery
- 31 July 2004
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 58 (1) , 99-105
- https://doi.org/10.1016/j.ejpb.2004.02.014
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Drug–drug interaction mediated by inhibition and induction of P-glycoproteinAdvanced Drug Delivery Reviews, 2003
- Role of P-Glycoprotein in PharmacokineticsClinical Pharmacokinetics, 2003
- The impact of P-glycoprotein efflux on enterocyte residence time and enterocyte-based metabolism of verapamilJournal of Pharmacy and Pharmacology, 2001
- The role of P-glycoprotein in limiting intestinal regional absorption of digoxin in ratsEuropean Journal of Pharmaceutical Sciences, 2001
- Comparative Studies on in Vitro Methods for Evaluating in Vivo Function of MDR1 P-GlycoproteinPharmaceutical Research, 2001
- Current methodologies used for evaluation of intestinal permeability and absorptionJournal of Pharmacological and Toxicological Methods, 2000
- Interrelationship Between Substrates and Inhibitors of Human CYP3A and P-GlycoproteinPharmaceutical Research, 1999
- Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestineProceedings of the National Academy of Sciences, 1997
- In Vitro Permeability Through Caco-2 Cells is not Quantitatively Predictive of in Vivo Absorption for Peptide-Like Drugs Absorbed via the Dipeptide Transporter SystemPharmaceutical Research, 1996
- In vitro systems for studying intestinal drug absorptionMedicinal Research Reviews, 1995